Rubin Lab

RUBIN’S REFLECTIONS

Follow on Twitter @IBDMD

SARS Vaccine and IBD Tweetorial Summary from December 1

SARS Vaccine and IBD Tweetorial Summary from December 1 David T. Rubin View Twitter Thread Here are my thoughts and a few updates about SARS-CoV-2 vaccines, and also about important implications for our IBD patients. Development of multiple SARS-CoV-2 vaccines in the...

Three waves of Illness from the COVID-19 Pandemic

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine I've been thinking about what comes next, and how can we get ahead of this, and propose the following for consideration. I believe that there will be three waves of illness from the...

How Does SARS-CoV-2 Become COVID-19 and How Can We Stop It?

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine Dear Colleagues, Here is my understanding of the different stages through which SARS-CoV-2 becomes COVID-19. I also added some thoughts on how we can prevent these stages and treat patients....

Pregnancy in the Setting of the SARS-CoV-2 Pandemic

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine Dear Colleagues, A lot of concern has recently come up regarding pregnancy in the setting of the SARS-CoV-2 pandemic. Here are some key points I found on this issue: Pregnancy is a state of...

How should we support the healthcare worker with IBD who is receiving immune therapies during the SARS-CoV-2 pandemic?

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine (Posted to IBD-circle.within3.com on March 21, 2020) Dear Colleagues, I have been fielding lots of questions about whether our IBD patients on immune therapies should stay home from work....

How IBD Can Affect Patients’ Career and School Choices

IBD, perhaps more than other chronic illnesses, can have a definite impact on a patient’s career choices and school performance. Therefore, I have definitely seen patients make decisions that are affected by their IBD. However, more often, I’ve seen patients overcome...

U.S. News & World Report features Dr. Rubin in “What’s the Difference Between Colitis and Crohn’s Disease?”

“A distinguishing feature of ulcerative colitis is that it's confined to the large intestine, which encompasses your colon and rectum, says Dr. David Rubin, chief of gastroenterology and a professor of medicine with University of Chicago Medicine....

Hospital-stay duration after IBD surgery not linked to sleep, activity

Second-year Pritzker medical student, Yangtian Yi, received Best Abstract in Surgery at AIBD 2019 for his abstract associating length of stay for IBD surgical patients with data collected from wearable devices. His oral presentation and abstract was reported on by...

‘We’ve Moved the Needle Quite Far’ in Management of Crohn Disease

Dr. Rubin discusses how the management of Crohn disease has changed over time, the importance of understanding the disease for proper management, and common mistakes in treatment that remain.

Definition of “healing” and sustained remission

The FDA and others have been interested in the role of histology for assessing “deeper” levels of disease control, with the premise that biopsy may reflect the state of the disease more accurately and perhaps more objectively than endoscopy, and certainly more than...

Read Dr. Rubin’s Comments on New Study Comparing HRQoL of Laparoscopic Ileocaecal Resection and Infliximab Treatment

Surgery an Alternative to Infliximab for Some People With Crohn’s Disease By Marilynn Larkin Dr. David Rubin, Chief of the Section of Gastroenterology, Hepatology, and Nutrition at the University of Chicago Medicine, agreed: “For some patients, as difficult as it may...

Dr. Rubin Taps in on “IBD Community Throwing Elbows Over Value of TDM” in Gastroenterology and Endoscopy News

Dr. Mark Silverberg, Dr. David T Rubin, Dr. Laura Targownik, and Dr. Charabaty excitingly discuss why IBD specialists are divided on the topic of therapeutic drug monitoring (TDM). “If the drug is going to work but isn’t present in the body, it doesn’t do its job,”...

G&E News Expert Picks by Dr. Rubin: Best of ECCO 2019

'In this installment of “Expert Picks,” David Rubin, MD, the Joseph B. Kirsner Professor of Medicine; the chief of the Section of Gastroenterology, Hepatology, and Nutrition; and a co-director of the Digestive Diseases Center at the University of Chicago Medicine and...

IBD As We Age: Thoughts on Treatment and Management For Age 40 and Beyond

There is a growing number of people diagnosed with IBD who are defined as “elderly”. This varies in definition but can be considered those who have IBD older than 50 or older than 60 or 65. I prefer the World Health Organization definition of >65. The two different...